Authors: Pavel Němec 1,2; Daniela Vysloužilová 3; Libor Hejsek 4; Jan Němčanský 5,6; Jan Studnička 4,7 Authors‘ workplace: Lexum – eye clinics, Czech Republic 1; 1st Faculty of Medicine, Charles University in Prague, Czech Republic 2; Department of Ophthalmology, University Hospital Brno Bohunice and, Faculty of Medicine, Masaryk University, Czech Republic 3; Department of Ophthalmology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Czech Republic 4; Department of Ophthalmology, University Hospital Ostrava, Czech Republic 5; Department of Craniofacial Sciences, Faculty of Medicine, University of Ostrava, Czech Republic 6; VISUS, spol. s. r. o., Czech Republic 7 Published in: Čes. a slov. Oftal., 82, 2026, No. Ahead of Print, p. 1-9 Category: Other articles doi: https://doi.org/10.31348/2026/2
Age-related macular degeneration is one of the leading causes of severe loss of sight in developed countries. Diagnostic procedures have developed dramatically in recent years, and modern imaging methods have contributed to improved options for population screening, targeted diagnostics, and monitoring of the treatment process. At the same time, new treatment options have also been developing rapidly. The recommended procedures summarize the current knowledge with the aim of unifying procedures for the diagnosis, classification, and treatment of age-related macular degeneration (AMD).
choroidal neovascular membrane – treatment – diagnostics – age-related macular degeneration – recommended procedures – anti-vascular endothelial growth factor – macular neovascularization
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
